BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7602317)

  • 1. Purkinje cell dendritic arbors in chick embryos following chronic treatment with an N-methyl-D-aspartate receptor antagonist.
    Vogel MW; Prittie J
    J Neurobiol; 1995 Apr; 26(4):537-52. PubMed ID: 7602317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of NMDA receptor subunit exchange alters Purkinje cell dendritic morphology in cerebellar slice cultures.
    Metzger F; Pieri I; Eisel UL
    Brain Res Dev Brain Res; 2005 Mar; 155(2):165-8. PubMed ID: 15804405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of class I metabotropic glutamate receptors limits dendritic growth of Purkinje cells in organotypic slice cultures.
    Sirzen-Zelenskaya A; Zeyse J; Kapfhammer JP
    Eur J Neurosci; 2006 Dec; 24(11):2978-86. PubMed ID: 17156359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purkinje cell dendritic tree development in the absence of excitatory neurotransmission and of brain-derived neurotrophic factor in organotypic slice cultures.
    Adcock KH; Metzger F; Kapfhammer JP
    Neuroscience; 2004; 127(1):137-45. PubMed ID: 15219676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CGP 39653 binding in the chick CNS after NMDA receptor antagonist treatment.
    White BH; Vogel MW
    J Neural Transm (Vienna); 1996; 103(11):1247-53. PubMed ID: 9013411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-methyl-D-aspartate receptor blockade inhibits estrogenic support of dendritic growth in a sexually dimorphic rat spinal nucleus.
    Hebbeler SL; Verhovshek T; Sengelaub DR
    J Comp Neurol; 2002 Sep; 451(2):142-52. PubMed ID: 12209833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMDA receptor expression in the mouse cerebellar cortex.
    Bilak SR; Bilak MM; Morest DK
    Synapse; 1995 Jul; 20(3):257-68. PubMed ID: 7570358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist.
    Ferkany JW; Hamilton GS; Patch RJ; Huang Z; Borosky SA; Bednar DL; Jones BE; Zubrowski R; Willetts J; Karbon EW
    J Pharmacol Exp Ther; 1993 Jan; 264(1):256-64. PubMed ID: 8423528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-2-chloropropionic acid-induced neurotoxicity is prevented by MK-801: possible role of NMDA receptors in the neuropathology.
    Widdowson PS; Wyatt I; Gyte A; Simpson MG; Lock EA
    Toxicol Appl Pharmacol; 1996 Jan; 136(1):138-45. PubMed ID: 8560467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the synaptogenesis in the cerebellar cortex through chronic treatment and immunocytochemistry of beta-bungarotoxin.
    Hirokawa N
    J Comp Neurol; 1979 May; 185(1):107-19. PubMed ID: 372258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphono-heptanoic acid (NPC 12626), a competitive N-methyl-D-aspartate receptor antagonist.
    Bobelis DJ; Balster RL
    J Pharmacol Exp Ther; 1993 Feb; 264(2):845-53. PubMed ID: 8437128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of TAG-1 and synaptophysin in the developing cerebellar cortex: relationship to Purkinje cell dendritic development.
    Stottmann RW; Rivas RJ
    J Comp Neurol; 1998 May; 395(1):121-35. PubMed ID: 9590550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purkinje cell and cerebellar effects following developmental exposure to PCBs and/or MeHg.
    Roegge CS; Morris JR; Villareal S; Wang VC; Powers BE; Klintsova AY; Greenough WT; Pessah IN; Schantz SL
    Neurotoxicol Teratol; 2006; 28(1):74-85. PubMed ID: 16309888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonist.
    Willetts J; Clissold DB; Hartman TL; Brandsgaard RR; Hamilton GS; Ferkany JW
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1055-62. PubMed ID: 8099615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of NMDA on spontaneous motility and its development in chick embryos.
    Sedlácek J
    Sb Lek; 1996; 97(3):293-302. PubMed ID: 9174373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential roles of NR2A and NR2B subtypes in NMDA receptor-dependent protein synthesis in dendrites.
    Tran DH; Gong R; Tang SJ
    Neuropharmacology; 2007 Aug; 53(2):252-6. PubMed ID: 17585958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of excess extracellular glutamate on dendrite growth from cerebral cortical neurons at 3 days in vitro: Involvement of NMDA receptors.
    Monnerie H; Shashidhara S; Le Roux PD
    J Neurosci Res; 2003 Dec; 74(5):688-700. PubMed ID: 14635220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of excitatory amino acids on neuromuscular development in the chick embryo.
    Calderó J; Ciutat D; Lladó J; Castán E; Oppenheim RW; Esquerda JE
    J Comp Neurol; 1997 Oct; 387(1):73-95. PubMed ID: 9331173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal dynamics of NMDA receptor-induced changes in spine morphology and AMPA receptor recruitment to spines.
    Lin H; Huganir R; Liao D
    Biochem Biophys Res Commun; 2004 Apr; 316(2):501-11. PubMed ID: 15020245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Golgi studies on Purkinje cell development in the frog during spontaneous metamorphosis. II. Details of dendritic development.
    Uray NJ; Gona AG
    J Comp Neurol; 1979 May; 185(2):237-51. PubMed ID: 311789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.